Home » Topics » Conferences

Conferences
RSS

Novel antibody with potential in treating RA investigated by Santen

Nov. 18, 1998

MMP inhibitor BMS-453 improves disease symptoms in mice with experimental arthritis

Nov. 18, 1998

SB pursues CCR5 antagonists for the treatment of inflammation

Nov. 18, 1998

Novel MMP inhibitor synthesized at Abbott shows potent antitumor activity in vivo

Nov. 18, 1998

New osteoarthritis treatment candidate blocks cartilage degradation

Nov. 18, 1998

MK-966 improves physical ability and quality of life in patients with OA, RA

Nov. 18, 1998

Collateral Therapeutics draws nearer to an effective gene therapy for CHF

Nov. 17, 1998

Gilead's adefovir dipivoxil extensively covered at AASLD meeting

Nov. 17, 1998

Putative cognition enhancer CR-2249 also exerts anxiolytic, antidepressant effects

Nov. 17, 1998

New dopamine D4 antagonist from Warner-Lambert characterized in preclinical studies

Nov. 17, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...